MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617097396 A) filed by Guangzhou Unirise Pharmaceutical Co. , Ltd.; Guangzhou Apichope Pharmaceutical Co. , Ltd.; Guangzhou Runlin Pharmaceutical Technology Co. , Ltd.; and Apichope Bio Pharmaceutical Co. , Ltd. on August 12, 2026, for Glp-1 Receptor Agonist, And Preparation Method Therefor And Use Thereof.
Inventors include Yang, Wenqian; Guan, Xinyu; Chen, Hongwei; Zhou, Xin; Su, Qiumin; Xu, Cong; Wang, Hui; Yu, Tianzhu; Zeng, Dongwen; and Chen, Ming.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: A class of compounds and the use thereof in a drug. Specifically, the present invention relates to a class of new compounds, a pharmaceutical composition containing the compounds, a method for preparing the compounds, and the use of the compounds or the pharmaceutical composition in the preparation of a drug for treating GLP-1 receptor agonist-mediated diseases and/or disorders, particularly the use in the preparation of a drug for treating diabetes, non-alcoholic fatty liver disease, obesity, myocardial infarction, heart failure, diabetic nephropathy, Parkinson's disease and Alzheimer's disease.
Disclaimer: Curated by HT Syndication.
